Close

JPMorgan Starts ISIS Pharmaceuticals (ISIS) at Neutral

October 4, 2013 6:41 AM EDT Send to a Friend
JPMorgan initiates coverage on ISIS Pharmaceuticals (NASDAQ: ISIS) with a Neutral ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login